Overview


According to FutureWise analysis the market for Minimally Invasive Surgery in 2023 is US$ 70.04 billion, and is expected to reach US$ 102.85 billion by 2031 at a CAGR of 4.92%.

Minimally invasive surgery enable surgeons to make fewer and smaller incisions thereby reducing the amount of blood loss. These procedures have been revolutionized by advancements in minimally invasive surgery devices. The use of minimally invasive technologies has improved patient outcomes and recovery around the world. By using voice control over a networked operating room, surgeons can advance video imaging through minimally invasive and robotic procedures. Minimally invasive robotic procedures provide surgeons with precision devices that use the same small incisions as conventional laparoscopy. The robotic system offers broader visualization of the operative field and precise control of minimally invasive surgery devices, which are two key differences.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Minimally Invasive Surgery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Minimally Invasive Surgery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott Laboratories
  • B. Braun Melsungen
  • AG, Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc,
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet
  • Medline Industries, Inc.
  • Apollo Hospitals Enterprise Limited
  • Huntington Hospital
  • Johns Hopkins Hospital
  • Massachusetts General Hospital
  • Rutland Medical Center
  • Saint Michael's Hospital
  • Singapore General Hospital
  • The Ottawa Hospital
  • University of Pittsburgh Medical Center
  • Washington Hospital Healthcare System

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Procedure

  • Laparoscopic Surgery
  • Robotic Surgery
  • Endoscopic Mucosal Resection
  • Endoscopic Submucosal Dissection
  • Transcatheter

By Disease Indication

  • Orthopedic Surgery
    • Knee
    • Spine
    • Shoulder
    • Others
  • Cardiac Surgery
    • Mitral Valve
    • Aortic Valve
    • Structural Heart Disease
    • Tricuspid Valve
    • Others
  • General Surgery
    • Gastrointestinal Surgery
    • Hepatobiliary and Pancreatic Surgery
  • Urology Surgery
  • Thoracic Surgery
  • Gynecology Surgery
  • Vascular Surgery
  • Cancer Surgery
  • Breast Surgery
  • Ear, Nose, and Throat Surgery
  • Bariatric Surgery
  • Cosmetic/Plastic Surgery
  • Neurosurgery
  • Others

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Minimally Invasive Surgery Market By Procedure, By Disease Indication, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Procedure launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Minimally Invasive Surgery Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Minimally Invasive Surgery Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Minimally Invasive Surgery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Minimally Invasive Surgery Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laparoscopic Surgery
        2. Robotic Surgery
        3. Endoscopic Mucosal Resection
        4. Endoscopic Submucosal Dissection
        5. Transcatheter

  • 8.   Minimally Invasive Surgery Market, By Disease Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Orthopedic Surgery
         1.1. Knee
         1.2. Spine
         1.3. Shoulder
         1.4. Others
        2. Cardiac Surgery
         2.1. Mitral Valve
         2.2. Aortic Valve
         2.3. Structural Heart Disease
         2.4. Tricuspid Valve
         2.5. Others
        3. General Surgery
         3.1. Gastrointestinal Surgery
         3.2. Hepatobiliary and Pancreatic Surgery
        4. Urology Surgery
        5. Thoracic Surgery
        6. Gynecology Surgery
        7. Vascular Surgery
        8. Cancer Surgery
        9. Breast Surgery
        10. Ear, Nose, and Throat Surgery
        11. Bariatric Surgery
        12. Cosmetic/Plastic Surgery
        13. Neurosurgery
        14. Others

  • 9.   Minimally Invasive Surgery Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers
        5. Others

  • 10.   North America Minimally Invasive Surgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Minimally Invasive Surgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Minimally Invasive Surgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Minimally Invasive Surgery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Procedures Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Procedure Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. B. Braun Melsungen
         2.1. Company Overview
         2.2. Procedure Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AG, Becton, Dickinson and Company
         3.1. Company Overview
         3.2. Procedure Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boston Scientific Corporation
         4.1. Company Overview
         4.2. Procedure Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. CONMED Corporation
         5.1. Company Overview
         5.2. Procedure Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Johnson & Johnson Services, Inc.
           6.1. Company Overview
          6.2. Procedure Portfolio
          6.3. SWOT Analysis
          6.4. Financial Overview
          6.5. Strategic Overview
         7. Medtronic plc,
          7.1. Company Overview
          7.2. Procedure Portfolio
          7.3. SWOT Analysis
          7.4. Financial Overview
          7.5. Strategic Overview
         8. Smith & Nephew plc
          8.1. Company Overview
          8.2. Procedure Portfolio
          8.3. SWOT Analysis
          8.4. Financial Overview
          8.5. Strategic Overview
         9. Stryker Corporation
          9.1. Company Overview
          9.2. Procedure Portfolio
          9.3. SWOT Analysis
          9.4. Financial Overview
          9.5. Strategic Overview
         10. Zimmer Biomet
          10.1. Company Overview
          10.2. Procedure Portfolio
          10.3. SWOT Analysis
          10.4. Financial Overview
          10.5. Strategic Overview
        11. Medline Industries, Inc.
          11.1. Company Overview
          11.2. Procedure Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
         12. Apollo Hospitals Enterprise Limited
          12.1. Company Overview
          12.2. Procedure Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. Huntington Hospital
          13.1. Company Overview
          13.2. Procedure Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
         14. Johns Hopkins Hospital
          14.1. Company Overview
          14.2. Procedure Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
         15. Massachusetts General Hospital
          15.1. Company Overview
          15.2. Procedure Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
           16. Rutland Medical Center
           16.1. Company Overview
           16.2. Procedure Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
         17. Saint Michael's Hospital
          17.1. Company Overview
          17.2. Procedure Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
         18. Singapore General Hospital
          18.1. Company Overview
          18.2. Procedure Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
         19. The Ottawa Hospital
          19.1. Company Overview
          19.2. Procedure Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview
         20. University of Pittsburgh Medical Center
          20.1. Company Overview
          20.2. Procedure Portfolio
          20.3. SWOT Analysis
          20.4. Financial Overview
          20.5. Strategic Overview
         21. Washington Hospital Healthcare System
          21.1. Company Overview
          21.2. Procedure Portfolio
          21.3. SWOT Analysis
          21.4. Financial Overview
          21.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients